Zobrazeno 1 - 10
of 102
pro vyhledávání: '"Janardan D. Khandekar"'
Autor:
Sean P. David, Henry M. Dunnenberger, Sarah Choi, Allison DePersia, Nadim Ilbawi, Christopher Ward, Dyson T. Wake, Janardan D. Khandekar, Yvette Shannon, Kristen Hughes, Nicholas Miller, Kathy A. Mangold, Linda M. Sabatini, Donald L. Helseth, Jianfeng Xu, Alan Sanders, Karen L. Kaul, Peter J. Hulick
Publikováno v:
Frontiers in Genetics, Vol 14 (2023)
Genomic and personalized medicine implementation efforts have largely centered on specialty care in tertiary health systems. There are few examples of fully integrated care systems that span the healthcare continuum. In 2014, NorthShore University He
Externí odkaz:
https://doaj.org/article/8d8d123c992c44b8bc21a5215773cee4
Autor:
Amanda Caplan, Kelly W. Bates, Carla Brioni, Aileen Santos, Linda M. Sabatini, Karen L. Kaul, Mercedes R. Carnethon, Janardan D. Khandekar, Philip Greenland
Publikováno v:
PLoS ONE, Vol 16, Iss 10 (2021)
Background Studies of outpatients with mild or moderate COVID-19 are uncommon. We studied: 1) association of symptoms with reverse transcriptase polymerase chain reaction (RT-PCR) test results; and 2) association of initial RT-PCR cycle threshold (Ct
Externí odkaz:
https://doaj.org/article/2115abcf2f5240b3980b069fe2b627eb
Autor:
W. Kyle Resurreccion, Brian T. Helfand, S. Lilly Zheng, Janardan D. Khandekar, Jun Wei, Joseph Hulsizer, Liana K. Billings, Clay Struve, Rong Na, Chi-Hsiung Wang, Jianfeng Xu, Zhuqing Shi, Michael S. Caplan
Publikováno v:
The American Journal of Tropical Medicine and Hygiene
Sickle cell trait (SCT) carriers inherit one copy of the Glu6Val mutation in the hemoglobin gene and is particularly common in Black individuals (5–10%). Considering the roles of hemoglobin in immune responses and the higher risk for coronavirus di
Autor:
Kristine Kuchta, Tilley Jenkins Vogel, Claire Hoppenot, E.D. Moore, Sahana Somasegar, Jean Hurteau, Annette W Sereika, Gustavo C. Rodriguez, Janardan D. Khandekar
Publikováno v:
Obstetrical & Gynecological Survey. 77:94-95
Molecular tumor profiling and next-generation sequencing are being increasingly utilized, but there are limited data on the therapeutic implications and potential benefits of targeted treatments. We aim to characterize gynecologic oncology patients r
Publikováno v:
Clinical Microbiology and Infectious Diseases. 6
Autor:
Carla Brioni, Aileen Santos, Kelly W. Bates, Amanda Caplan, Janardan D. Khandekar, Philip Greenland, Mercedes R. Carnethon, Karen L. Kaul, Linda Sabatini
Publikováno v:
PLoS ONE, Vol 16, Iss 10, p e0258970 (2021)
PLoS ONE, Vol 16, Iss 10 (2021)
PLoS ONE
PLoS ONE, Vol 16, Iss 10 (2021)
PLoS ONE
Background Studies of outpatients with mild or moderate COVID-19 are uncommon. We studied: 1) association of symptoms with reverse transcriptase polymerase chain reaction (RT-PCR) test results; and 2) association of initial RT-PCR cycle threshold (Ct
Autor:
Nadim Ilbawi, Amy A. Lemke, K Yu, Peter J. Hulick, Janardan D. Khandekar, Henry M. Dunnenberger, Jared Hammernik
Publikováno v:
Molecular Genetics and Metabolism. 132:S360-S361
Autor:
Brian T. Helfand, Rong Na, Jianfeng Xu, Liana K. Billings, W. Kyle Resurreccion, Zhuqing Shi, S. Lilly Zheng, Chi-Hsiung Wang, Janardan D. Khandekar, Jun Wei
Although cancer has been associated with COVID-19 risk and mortality in hospital-based studies, few population-based studies have been reported. Utilizing data from the UK Biobank (UKB), a population-based prospective cohort, we formally tested the a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dacb73ed433b7a100d3b91f6dc535116
https://doi.org/10.1101/2020.07.10.20151076
https://doi.org/10.1101/2020.07.10.20151076
Autor:
Brian T. Helfand, Rong Na, S. Lilly Zheng, W. Kyle Resurreccion, Janardan D. Khandekar, Clay Struve, Jun Wei, Joseph Hulsizer, Zhuqing Shi, Michael S. Caplan, Jianfeng Xu
We tested the hypothesis that patients with sickle cell trait (SCT), a common condition in individuals of African descent, have increased risk and mortality for coronavirus disease (COVID-19) in the UK Biobank. By June 17, 2020, 1,550 of 7,668 (20%)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c63f0aaa91b52a261579ca0651cf319
https://doi.org/10.1101/2020.07.02.20145359
https://doi.org/10.1101/2020.07.02.20145359
Autor:
Aarti K. Bhatia, Robert M. Arusell, Luis Baez-Diaz, Kishan J. Pandya, Ju Whei Lee, Charlotte Jacobs, George L. Adams, Seth A. Reiner, Eamonn Patrick Dunphy, Barbara Burtness, Philip Rubin, Shuli Li, Yi Li, Janardan D. Khandekar, Paul J. Limburg, Harlan A. Pinto, Paul Celano
Publikováno v:
Cancer. 123:4653-4662
BACKGROUND 13-Cis retinoic acid (13-CRA) is a synthetic vitamin A derivative. High-dose 13-CRA in patients with squamous cell cancers of the head and neck (SCCHNs) reduces the incidence of second primary tumors (SPTs). The authors report long-term re